quinoxalines has been researched along with u 0126 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Russo, AF; Wood, JL | 1 |
Roberts, RE | 1 |
Cussac, D; Denis, C; Paris, H; Schaak, S | 1 |
Arendt, T; Barmashenko, G; Behrbohm, J; Brückner, MK; Gärtner, U; Heumann, R; Holzer, M; Hümmeke, M; Mittmann, T; Palm, K; Seeger, G; Wahle, P; Yan, L | 1 |
He, S; Li, X; Martin, DT; Tian, Y; Weiss, RM | 1 |
5 other study(ies) available for quinoxalines and u 0126
Article | Year |
---|---|
Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter.
Topics: Animals; Base Sequence; Butadienes; Cell Line; CHO Cells; Cricetinae; Enzyme Inhibitors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Genes, Reporter; Imidazoles; Kinetics; Luciferases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; Molecular Sequence Data; Neurons; Nitriles; Promoter Regions, Genetic; Pyridines; Quinoxalines; Recombinant Proteins; Serotonin Receptor Agonists; Transcription, Genetic; Transfection; Tryptophan Hydroxylase | 2001 |
Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Forelimb; Genistein; Isoflavones; Mitogen-Activated Protein Kinases; Nifedipine; Nitriles; Potassium Chloride; Quinoxalines; Receptors, Adrenergic, alpha-2; Signal Transduction; Swine; Vasoconstriction; Vasodilator Agents; Veins; Verapamil | 2001 |
alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Arachidonic Acid; Bacterial Proteins; Brimonidine Tartrate; Butadienes; Cell Line; Cell Nucleus; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; MAP Kinase Signaling System; Matrix Metalloproteinases; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Biological; Nitriles; Pertussis Toxin; Phosphorylation; Protein Binding; Proteins; Quinacrine; Quinazolines; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Swine; Transcriptional Activation; Tyrphostins; Virulence Factors, Bordetella | 2002 |
Neuronal activation of Ras regulates synaptic connectivity.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; Axons; Butadienes; Cell Count; Cell Size; Cells, Cultured; Cerebral Cortex; Dendrites; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Histocytochemistry; Immunohistochemistry; In Vitro Techniques; Long-Term Potentiation; Mice; Mice, Transgenic; Microscopy, Electron; Mitogen-Activated Protein Kinase Kinases; Nitriles; Patch-Clamp Techniques; Pyramidal Cells; Quinoxalines; ras Proteins; Rats; Synapses; Synaptic Transmission; Synaptophysin; Time Factors | 2004 |
Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
Topics: Butadienes; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hydrazines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Nitriles; Quinoxalines; Urinary Bladder Neoplasms | 2019 |